Grants for Native American tribal organizations - Health

The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit limited applications for continuation of an established nuclear magnetic resonance (NMR) research resource consisting of raw and meta-data from natural products ranging from crude extracts to purified substances; with the capacity to upload, download, store, search and analyze raw NMR data. The purpose of this limited competition is to promote sustainability, scaling and wider community inclusiveness of the established NMR research resource. This notice of funding opportunity (NOFO) is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Leveraging Big Data to Understand Natural Product Impacts on Whole Person Health (R01).

The purpose of this Notice of Funding Opportunity (NOFO) is to support the establishment of one (1) Center of Excellence (CoE) to coordinate the research community of infectious and immune-mediated disease (IID) computational modelers and advance IID modeling research across biological scales. The CoE must include three (3) coordinating cores and two (2) research projects to advance and integrate bridge models across scales in the context of IID, including HIV/AIDS. The CoE will accelerate multi-scale model development, sharing and re-use, and support collaboration to benefit the entire IID research community.

This funding opportunity supports researchers and organizations in developing new small molecule therapies for mental and neurological disorders, focusing on innovative drug discovery methods without involving clinical trials.

This funding opportunity supports research projects that develop and implement effective strategies to reduce overdose deaths and improve addiction treatment across various settings, targeting diverse populations and addressing health disparities.

The "Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas" grant is a funding opportunity offered by the U.S. Department of Health and Human Services to support comprehensive health care and services for low-income individuals with HIV, particularly in underserved areas, with the aim of improving health outcomes and access to care.

This funding opportunity provides financial support for research focused on the long-term health outcomes of youth and young adults in the U.S. living with perinatally acquired HIV, emphasizing the impacts of antiretroviral therapy and associated health challenges.

This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.

This funding opportunity provides financial support to a variety of organizations to strengthen public health systems in Cote d'Ivoire, focusing on improving disease detection, response, and prevention capabilities.

This grant provides funding for nonprofit organizations and local government units in Southwest Minnesota to purchase equipment and make facility improvements that enhance their ability to support community arts initiatives.

The National Fish and Wildlife Foundation (NFWF) is seeking proposals for its Southeast Aquatics Fund to voluntarily conserve aquatic habitats in the southeastern United States and Texas. This grant program directly aligns with NFWF's mission to sustain, restore, and enhance the nation's fish, wildlife, and plants. The fund's priorities are informed by the Longleaf Forests and Rivers Business Plan, adopted in 2018 and updated in 2023, which aims to conserve the extraordinary biodiversity across the Southeast. The primary target beneficiaries of this program are aquatic ecosystems and the diverse array of species that inhabit them, particularly those identified as focal species in the Conasauga River (GA) and Middle Coosa (AL) watersheds. These include various endemic and native fishes like the Alabama shiner, banded sculpin, blue shiner, and trispot darter. The impact goal is to advance specific goals and objectives of the Longleaf Forests and Rivers Business Plan and other relevant conservation plans, ultimately leading to healthier aquatic habitats. The program prioritizes work in northern Alabama and Georgia due to measurement and monitoring constraints, with funding available for a wide range of activities in the Conasauga River (GA) and Locust Fork and Middle Coosa (AL) watersheds. Projects benefiting the focal species in these areas will receive priority. The strategic priorities of the NFWF, as evidenced by the Longleaf Forests and Rivers Business Plan, emphasize a suite of aquatic species as indicators of healthy aquatic habitats in prioritized watersheds, reflecting a theory of change that by protecting these indicator species, the broader ecosystem health will improve. Expected outcomes include the conservation of aquatic habitat, the advancement of specific goals outlined in the Longleaf Forests and Rivers Business Plan, and positive impacts on focal species populations. While not explicitly detailed as "measurable results" in the provided text, the focus on indicator species suggests that the health and population trends of these species would serve as key metrics for success. Projects are anticipated to have a completion time of 24–36 months, with grant awards ranging from $150,000 to $500,000 from approximately $8.45 million available in 2024.

This grant provides funding for researchers and organizations to develop innovative medical countermeasures for treating acute chemical exposures resulting from terrorist attacks or accidental releases, enhancing national preparedness for chemical emergencies.

This grant provides funding to U.S.-based educational institutions, nonprofits, and community organizations to improve mental health and substance use treatment practices in outpatient settings, particularly for underserved populations.

This grant provides funding for research projects that improve mental health services and outcomes for young people experiencing early stages of psychosis by promoting data-driven care and collaboration among specialized treatment programs across the United States.

This funding opportunity provides financial support for organizations to archive and document child health and human development data sets, facilitating their accessibility for secondary analysis by researchers.

This funding opportunity provides financial support for researchers and organizations developing innovative long-acting treatments for HIV and related co-infections, aiming to improve patient adherence and health outcomes.

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development and validation of reagents/tools to support research to characterize cellular and molecular constituents of the bat immune system and for the study of protective innate and adaptive immune mechanisms in bats. The Research Resource Program established by this NOFO will participate within a collaborative research network to advance understanding of the bat immune response. This NOFO will support the establishment and operation of a Bat Immunology Research Resource Program for the development and validation of reagents/tools for use in immunological studies using the bat model system. The recipient will participate in the Bat Immunology Network, which will consist of the Research Resource Program, the research projects supported by RFA-AI-23-068, and possible other participants as determined by NIAID. The Research Resource Program will conduct reagent/tool development and validation using appropriate systems, which includes testing against multiple bat species. While other members of the Bat Immunology Network may assist in validation efforts, reagent/tool validation is the responsibility of the Research Resource Program. Reagents/tools developed by the Research Resource Program will be provided to the research projects of the Bat Immunology Network. Reagents/tools will be made available to the broader research community through technology transfer arrangements, deposition to nonprofit repositories, and/or timely transfer to industry for commercialization. Areas of high priority include, but are not limited to, the development and validation of the following: Soluble immune molecules (e.g., cytokines, chemokines) for use in tissue culture or in vivo animal studies Antibodies or other probes/detection markers for use in cellular phenotyping, functional studies and/or immunoassays

This grant provides funding to K-12 schools, healthcare facilities, and faith-based organizations in Arizona to create and maintain sustainable green spaces that improve environmental quality and community well-being.

This funding opportunity supports innovative research aimed at developing new strategies for curing HIV at the start of antiretroviral therapy, targeting researchers and institutions focused on reducing the HIV reservoir and improving immune responses.

This funding opportunity supports research projects that analyze existing national data to improve healthcare access and outcomes for children and adolescents with autism and developmental disabilities, particularly in underserved populations.

This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. Transition to the R33 phase is not guaranteed for all grants awarded under this FOA. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds.